FTC Says Allergan Must Face Lidoderm Generic Delay Suit
The Federal Trade Commission told a Pennsylvania federal judge on Tuesday that it rightfully sued Allergan PLC alongside Endo Pharmaceuticals and other companies over allegedly unlawful delays in generic drug competition...To view the full article, register now.
Already a subscriber? Click here to view full article